Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Loh

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neurology|January 1, 2016
CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patientsLinda A Lieberman, Wanyong Zeng, Carol Singh, et al.
Journal of the Air & Waste Management Association (1995)|November 16, 2004
Megacities and atmospheric pollutionJudith C Chow, John G Watson, Jitendra J Shah, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1Marina M Bellet, Yasukazu Nakahata, Mohamed Boudjelal, et al.
Cell Cycle (Georgetown, Tex.)|July 30, 2013
Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanismBasil P Hubbard, Christine Loh, Ana P Gomes, et al.
Immunology|December 24, 2015
Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivoDaliya Banerjee, Linlin Zhao, Lan Wu, et al.
Plos One|October 3, 2012
SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activityHongying Yang, Wei Zhang, Heng Pan, et al.
Biochemistry|April 28, 2007
Structure of the catalytic domain of human polo-like kinase 1Michael Kothe, Darcy Kohls, Simon Low, et al.
Journal of Medicinal Chemistry|August 27, 2025
Knowledge and Structure-Based Drug Design of 15-PGDH InhibitorsLeela S Dodda, Sebastien Campos, David Ciccone, et al.
Frontiers in Immunology|September 12, 2022
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responsesGiulia Monticone, Zhi Huang, Fred Csibi, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2010
The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitorsHengmiao Cheng, Jacqui Hoffman, Phuong Le, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neurology|January 1, 2016
CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patientsLinda A Lieberman, Wanyong Zeng, Carol Singh, et al.
Journal of the Air & Waste Management Association (1995)|November 16, 2004
Megacities and atmospheric pollutionJudith C Chow, John G Watson, Jitendra J Shah, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1Marina M Bellet, Yasukazu Nakahata, Mohamed Boudjelal, et al.
Cell Cycle (Georgetown, Tex.)|July 30, 2013
Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanismBasil P Hubbard, Christine Loh, Ana P Gomes, et al.
Immunology|December 24, 2015
Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivoDaliya Banerjee, Linlin Zhao, Lan Wu, et al.
Plos One|October 3, 2012
SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activityHongying Yang, Wei Zhang, Heng Pan, et al.
Biochemistry|April 28, 2007
Structure of the catalytic domain of human polo-like kinase 1Michael Kothe, Darcy Kohls, Simon Low, et al.
Journal of Medicinal Chemistry|August 27, 2025
Knowledge and Structure-Based Drug Design of 15-PGDH InhibitorsLeela S Dodda, Sebastien Campos, David Ciccone, et al.
Frontiers in Immunology|September 12, 2022
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responsesGiulia Monticone, Zhi Huang, Fred Csibi, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2010
The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitorsHengmiao Cheng, Jacqui Hoffman, Phuong Le, et al.
Pageof 3